文献速递妇科生殖医学

基于调查的药物流产资格自评与临床医生评估准确性的比较

Accuracy of survey-based assessment of eligibility for medication abortion compared with clinician assessment.
PubMed 文献 · Am J Obstet Gynecol · 2025-01-09

这项诊断准确性研究从9家流产机构招募1386名寻求流产者,比较基于自报病史的药物流产资格与临床医生评估的一致性,以77天为孕龄上限。自评总体诊断准确度AUC为0.65(95%CI 0.63-0.67),敏感性92.2%(95%CI 88.6-94.9),特异性37.8%(95%CI 34.9-40.7);仅1.7%自评合格而临床医生判定不合格,但48.5%自评不合格而临床医生判定合格。

要点

  • 基于病史的筛查能有效确保极少不合格者获得药物流产(仅1.7%自评合格而临床医生判定不合格)。
  • 但48.5%自评不合格者实际临床医生判定合格,提示需更特异的筛查问题。
  • 自评总体诊断准确度AUC为0.65(95%CI 0.63-0.67),敏感性92.2%,特异性37.8%。

核心结论

  • 基于病史的筛查方案在确保极少不合格者接受药物流产方面高度有效,但相当比例实际合格者被筛查为不合格,提示需要更特异的筛查问题。

研究设计与样本

  • 诊断准确性研究,从9家流产机构招募寻求药物或手术流产者,年龄≥15岁,英语或西班牙语,招募机构未做过超声,共1386人。
  • 超声前调查药物流产资格,包括估计孕龄、病史、禁忌证及异位妊娠风险因素如疼痛和出血症状,以77天为孕龄上限。
  • 比较基于自报病史的资格与随后的临床医生评估,聚焦总体诊断准确度(AUC)、敏感性、特异性及不一致比例。

主要发现

  • 1386名参与者中,22.1%根据临床医生评估不符合药物流产资格。
  • 自评总体诊断准确度AUC为0.65(95%CI 0.63-0.67),敏感性92.2%(95%CI 88.6-94.9),特异性37.8%(95%CI 34.9-40.7)。
  • 24名(1.7%)自评合格而临床医生判定不合格;672名(48.5%)自评不合格而临床医生判定合格。
  • 患者报告的最常见禁忌证包括不明原因疼痛(55.5%)、孕龄>77天(36.5%)和贫血(29.0%)。
  • 不明原因疼痛单独识别临床医生担心异位妊娠的敏感性差(41.7%;95%CI 15.2-72.3);移除不明原因疼痛作为筛查标准后准确度更高(0.71;95%CI 0.69-0.74)(P<.001)。

关键数值与推荐

  • 以77天作为药物流产的孕龄上限。
  • 自评合格而临床医生判定不合格者24名(1.7%),自评不合格而临床医生判定合格者672名(48.5%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With increasingly restricted access to facility-based abortion in the United States, pregnant people are increasingly relying on models of care that use history-based or no-test approaches for eligibility assessment. Minimal research has examined the accuracy of abortion patients' self-assessment of eligibility for medication abortion using their health history. This step is necessary for ensuring optimal access to history-based or no-test models, as well as potential over-the-counter access. OBJECTIVE: This study aimed to examine the accuracy of pregnant people's eligibility for medication abortion as determined using their self-reported health history, compared with clinician assessments using ultrasound and other tests. STUDY DESIGN: In this diagnostic accuracy study, we recruited people seeking medication or procedural abortion from 9 abortion facilities, aged ≥15 years, English- or Spanish-speaking, and with no prior ultrasound conducted at the recruitment facility. Before ultrasound, we surveyed participants on medication abortion eligibility, including estimated gestational duration, medical history, contraindications, and ectopic pregnancy risk factors such as pain and bleeding symptoms. We compared patients' eligibility based on self-reported history with subsequent clinician assessment, focusing on overall diagnostic accuracy, or area under the receiver operating characteristic curve, sensitivity, specificity, and proportion with discordant patient and clinician eligibility assessment, using 77 days as the upper gestational duration limit. RESULTS: Overall, 22.1% of 1386 participants were ineligible for medication abortion according to clinician assessment. Overall diagnostic accuracy of self-assessment was acceptable (area under the receiver operating characteristic curve=0.65; 95% confidence interval, 0.63-0.67), with sensitivity of 92.2% (88.6-94.9) and specificity of 37.8% (34.9-40.7). Very few participants (n=24; 1.7%) self-assessed as eligible when the clinician deemed them ineligible; many more (n=672; 48.5%) self-assessed as ineligible when the clinician deemed them eligible. The most common patient-reported contraindications included unexplained pain (55.5%), gestational duration >77 days (36.5%), and anemia (29.0%). On its own, unexplained pain had poor sensitivity in identifying those with clinician concern for ectopic pregnancy (41.7%; 95% confidence interval, 15.2-72.3). Removing unexplained pain as a screening criterion resulted in higher accuracy (0.71; 95% confidence interval, 0.69-0.74) (P<.001). CONCLUSION: History-based screening protocols are highly effective at ensuring that few people receive medication abortion when ineligible. However, a sizable group screens as ineligible when they are in fact eligible, suggesting a need for more specific screening questions.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Ralph LJ, Ehrenreich K, Kaller S, et al. Accuracy of survey-based assessment of eligibility for medication abortion compared with clinician assessment. Am J Obstet Gynecol. 2025. PMID: 39798911. doi:10.1016/j.ajog.2025.01.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。